期刊文献+

常山酮的合成方法研究 被引量:3

Study on the Synthetic Technique of Halofuginone
下载PDF
导出
摘要 本文对常山酮(halofuginone)的合成方法进行了研究和改进,以2-甲基-3-羟基吡啶为起始原料,其甲基化产物与乙腈加成后经Rh/Al2O3选择性还原得(3-甲氧基-2-哌啶基)-丙酮,再经溴代、N-保护后与6-氯-7-溴-4(3H)-喹唑啉酮偶联,产物经水解脱保护得目标化合物6-氯-7-溴-3-(3-(3-羟基-2-哌啶基)-丙酮基)-4(3H)-喹唑啉酮氢溴酸盐,通过6步反应制得了常山酮,总收率为11.6%,为常山酮的工业化生产提供了可能。目标产物和各步中间体结构经MS1、H NMR和13CNMR确证。 The synthesis of Halofuginone was researched and improved in this artical. Halofuginone was synthesized from 2-methylpyridin-3-ol by methylation addition and selective catalytic reduction to give 1- (3-methoxypiperidin-2-yl)propan-2-one, which was subjected to bromination, N-protection, substitution to afford allyl 2-( 3-( 7-bromo-6-chloro-4-oxo-quinazolin-3 ( 4H)-yl)-2-oxopropyl)-3-methoxypiperidine-1- carboxylate, and finally hydrolation with acid to give the product. The chemical structures of halofuginone and its intermediate were confirmed by 1H NMR, 13 C NMR and MS. The total yield ratio of production was 11.7%. The new synthetic route provided the possibility for industrial production of Halofuginone.
出处 《中国海洋大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第9期67-70,共4页 Periodical of Ocean University of China
基金 青岛市科技攻关计划(08-2-4-4-nsh) 科技部科技人员服务企业计划(2009GJC60017)资助
关键词 常山酮 抗球虫药 合成方法 halofuginone anti-coccidiosis synthetic method
  • 相关文献

参考文献2

共引文献11

同被引文献55

  • 1陈勇,程明,刘春霞.肝脏毒性中药的研究现状与展望[J].中草药,2004,25(11):1315-1316. 被引量:19
  • 2程文虹,张震宇.常山酮的抗球虫效果[J].饲料研究,2005,28(6):35-37. 被引量:12
  • 3周后元,方资婷,叶鼎彝,杨基懋,王其灼.维生素B_6噁唑法合成新工艺[J].中国医药工业杂志,1994,25(9):385-389. 被引量:19
  • 4邓君丽,寻桂华.常山与白常山的比较鉴别[J].中草药,1996,27(6):369-370. 被引量:4
  • 5陆玮,陆思源.肝纤维化诊断和治疗进展[J].国际消化病杂志,2006,26(1):2-4. 被引量:8
  • 6Choi E T, Callow A D, Sehgal N L, et al. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia [J]. Arch Surg, 1995, 130(3): 257-261.
  • 7Hasegawa M, Matsushita Y, Horikawa M, et al. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis [J]. Arthritis Rheum, 2009, 60(11): 3465-3475.
  • 8Nawroth I, Alsner J, Behlke M A, et al. Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFct prevents radiation-induced fibrosis [J]. Radiother Oncol, 2010, 97(1): 143-148.
  • 9Yavas G, Calik M, Calik G, et al. The effect of Halofuginone in the amelioration of radiation induced- lung fibrosis [J]. MedHypotheses, 2013, 80(4): 357-359.
  • 10Grudzien M M, Low P S, Manning P C, et al. The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells [J]. Fertil Steril, 2010, 93(4): 1290-1298.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部